Drawing for DERMATOLOGY RX REDEFINED

USPTO serial 99436233

DERMATOLOGY RX REDEFINED

Reviewed by CopyMark Law Group

Status 819
Filing date
Status date
Registration date
—
Examiner
MCMORROW, RONALD G
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with DERMATOLOGY RX REDEFINED?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael J Purvis

Michael J Purvis SKNV3265 West McNab RoadPompano Beach, FL 33069United States

Goods and services

ClassDescriptionStatusFirst use
035Mail order pharmacy services; Pharmaceutical services, namely, processing online and telephoneprescription orders in retail and central fill pharmacies; Retail pharmacy servicesACTIVEMar 30, 2024
040Custom manufacture of pharmaceuticals, chemotherapy drugs, antibiotics, and medicines bypharmaceutical compounders.ACTIVEMar 30, 2024
044Pharmaceutical compounding services; pharmaceutical advice; preparation of prescriptions bypharmacistsACTIVEMar 30, 2024

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 10, 2026SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Nov 10, 2026CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Nov 10, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Nov 9, 2026IUAFUSE AMENDMENT FILED—
Nov 9, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 26, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 26, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 26, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 19, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 24, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 24, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 18, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 3, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 2, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Mar 2, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 2, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 2, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 27, 2026DOCKASSIGNED TO EXAMINER—
Feb 11, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 10, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 10, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance